We are live on ! Find out more
AMPH icon

Amphastar Pharmaceuticals

271 hedge funds and large institutions have $1.47B invested in Amphastar Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 89 increasing their positions, 98 reducing their positions, and 53 closing their positions.

New
Increased
Maintained
Reduced
Closed

21% more call options, than puts

Call options by funds: $3.17M | Put options by funds: $2.61M

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

0.92% less ownership

Funds ownership: 70.69%69.78% (-0.92%)

9% less repeat investments, than reductions

Existing positions increased: 89 | Existing positions reduced: 98

2% less funds holding

Funds holding: 277271 (-6)

11% less first-time investments, than exits

New positions opened: 47 | Existing positions closed: 53

30% less capital invested

Capital invested by funds: $2.09B → $1.47B (-$622M)

Holders
271
Holders Change
-6
Holders Change %
-2.17%
% of All Funds
3.9%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
47
Increased
89
Reduced
98
Closed
53
Calls
$3.17M
Puts
$2.61M
Net Calls
+$553K
Net Calls Change
-$610K
Name Holding Trade Value Shares
Change
Change in
Stake
Connor, Clark & Lunn Investment Management (CC&L)
51
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$3.89M +$2.45M +47,388 +115%
Squarepoint
52
Squarepoint
New York
$3.6M -$71.9K -1,393 -2%
UBS Group
53
UBS Group
Switzerland
$3.53M +$484K +9,366 +13%
VOYA Investment Management
54
VOYA Investment Management
Georgia
$3.5M -$1.15M -22,309 -22%
State of Wisconsin Investment Board
55
State of Wisconsin Investment Board
Wisconsin
$3.42M +$1.81M +35,054 +82%
TI
56
Trexquant Investment
Connecticut
$3.41M +$2M +38,766 +100%
Public Sector Pension Investment Board (PSP Investments)
57
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$3.36M -$49.1K -950 -1%
Swiss National Bank
58
Swiss National Bank
Switzerland
$3.32M -$77.5K -1,500 -2%
MAP
59
Moody Aldrich Partners
Massachusetts
$3.31M +$639K +12,364 +20%
EA
60
Ellsworth Advisors
Ohio
$3.22M +$4.19M +81,165 New
Barclays
61
Barclays
United Kingdom
$3.11M +$392K +7,590 +12%
Citadel Advisors
62
Citadel Advisors
Florida
$2.97M -$2.5M -48,502 -42%
First Trust Advisors
63
First Trust Advisors
Illinois
$2.95M +$1.04M +20,169 +43%
Allspring Global Investments
64
Allspring Global Investments
North Carolina
$2.84M +$1.27M +24,678 +62%
HSA
65
Hussman Strategic Advisors
Maryland
$2.77M +$3.25M +63,000 New
BNP Paribas Financial Markets
66
BNP Paribas Financial Markets
France
$2.69M -$1.89M -36,573 -37%
RG
67
Renaissance Group
Kentucky
$2.61M +$567K +10,983 +23%
Wells Fargo
68
Wells Fargo
California
$2.51M +$1.06M +20,579 +56%
AQR Capital Management
69
AQR Capital Management
Connecticut
$2.51M +$2.29M +44,310 +348%
CSS
70
Cubist Systematic Strategies
Connecticut
$2.42M +$464K +8,985 +19%
ECM
71
ExodusPoint Capital Management
New York
$2.39M +$2.18M +42,235 +343%
New York State Common Retirement Fund
72
New York State Common Retirement Fund
New York
$2.37M +$15.5K +301 +0.6%
CS
73
Credit Suisse
Switzerland
$2.25M
State of New Jersey Common Pension Fund D
74
State of New Jersey Common Pension Fund D
New Jersey
$2.22M +$240K +4,650 +10%
SI
75
Shaker Investments
Ohio
$2.16M +$5.78K +112 +0.2%

AMPH Hedge Fund Activity: Q1 2024 in Review

271 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Amphastar Pharmaceuticals (AMPH) for Q1 2024, worth a combined $1.47B — down 30% from $2.09B a quarter earlier.

Sellers outnumbered buyers: 53 funds closed out of AMPH and 47 opened new positions — a net loss of 6 holders — while 98 trimmed existing stakes and 89 added.

The largest buyer was American Century Companies, adding an estimated $14.5M. The largest seller was Federated Hermes, cutting an estimated $61.8M.

  • 271 institutional investors held Amphastar Pharmaceuticals (AMPH) as of Q1 2024, down from 277 in Q4 2023.
  • Funds reported $1.47B of Amphastar Pharmaceuticals stock for Q1 2024, down 30% quarter-over-quarter.
  • 47 funds opened new Amphastar Pharmaceuticals positions in Q1 2024 and 53 closed out, a net change of -6 holders.
  • The largest Amphastar Pharmaceuticals buyer in Q1 2024 was American Century Companies, an estimated $14.5M added.
  • The largest Amphastar Pharmaceuticals seller in Q1 2024 was Federated Hermes, an estimated $61.8M sold.

Based on aggregated 13F filings for Q1 2024.